The research carried out by Pollard, and Zeisleret al., reviewed the measurement of interleukin 1-alpha (IL-1α) in the serum of ovarian cancer patients and concluded that there is increase level in the ovarian cancer patients as compared to controls [10, 28]. This evidence concerns the gene IL1A and ovarian carcinoma.